Action 688319 CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Chengdu Olymvax Biopharmaceuticals Inc.

Actions

688319

CNE1000051H8

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
10 CNY +1,11 % Graphique intraday de Chengdu Olymvax Biopharmaceuticals Inc. +2,77 % -36,71 %
25/04 Chengdu Olymvax Biopharmaceuticals Inc. présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
27/02 Chengdu Olymvax Biopharmaceuticals Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Olymvax Biopharmaceuticals Withdraws Application for Combined Influenza Vaccine
Olymvax Biopharmaceuticals Grants Keyuan Xinhai Marketing Rights for Meningococcal Vaccines
Olymvax Biopharmaceuticals to Push Through Phase III Trial Into Recombinant Staphylococcus Aureus Vaccine
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Chengdu Olymvax Biopharmaceuticals Inc.(XSSC:688319) added to S&P Global BMI Index
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Chinese healthcare stocks hit by stepped up anti-graft crackdown
Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange A Share Index
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange Composite Index
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 688319
  4. Actualités Chengdu Olymvax Biopharmaceuticals Inc.
  5. Autres langues